| pubmed-article:1363513 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1363513 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
| pubmed-article:1363513 | lifeskim:mentions | umls-concept:C0205474 | lld:lifeskim |
| pubmed-article:1363513 | lifeskim:mentions | umls-concept:C0439849 | lld:lifeskim |
| pubmed-article:1363513 | lifeskim:mentions | umls-concept:C1521747 | lld:lifeskim |
| pubmed-article:1363513 | lifeskim:mentions | umls-concept:C1707864 | lld:lifeskim |
| pubmed-article:1363513 | lifeskim:mentions | umls-concept:C1510438 | lld:lifeskim |
| pubmed-article:1363513 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:1363513 | lifeskim:mentions | umls-concept:C0549193 | lld:lifeskim |
| pubmed-article:1363513 | lifeskim:mentions | umls-concept:C1518371 | lld:lifeskim |
| pubmed-article:1363513 | pubmed:issue | 6B | lld:pubmed |
| pubmed-article:1363513 | pubmed:dateCreated | 1993-4-9 | lld:pubmed |
| pubmed-article:1363513 | pubmed:abstractText | The erbB2-encoded protein p185 was determined in 130 breast cancer specimens and in 29 non-malignant breast tissues using a recently available ELISA method. The assay showed good characteristics of precision and accuracy. In the non-malignant tissue p185 concentrations were normally distributed and directly correlated with estrogen receptors (ER) and progesterone receptors (PR). In cancer tissue p185 showed higher concentrations than in non-malignant tissue. No relationships were found between p185 and the main clinical and pathological parameters, except that a direct association with nuclear grade was found. We have categorized the breast cancer samples according to p185 concentrations as p185-negative (concentrations lower than the higher non-malignant tissue) and p185-positive. Our data suggested a different behaviour of p185 in samples with low or high p185 concentrations. Indeed, in p185-negative samples the concentrations were directly correlated with both ER and PR. Conversely, p185-positive samples were directly associated with node status and pT, and inversely associated with ER and PR. | lld:pubmed |
| pubmed-article:1363513 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1363513 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1363513 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1363513 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1363513 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1363513 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1363513 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1363513 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1363513 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1363513 | pubmed:issn | 0250-7005 | lld:pubmed |
| pubmed-article:1363513 | pubmed:author | pubmed-author:SpinaMM | lld:pubmed |
| pubmed-article:1363513 | pubmed:author | pubmed-author:GionMM | lld:pubmed |
| pubmed-article:1363513 | pubmed:author | pubmed-author:MarconatoRR | lld:pubmed |
| pubmed-article:1363513 | pubmed:author | pubmed-author:DittadiRR | lld:pubmed |
| pubmed-article:1363513 | pubmed:author | pubmed-author:DonisiP MPM | lld:pubmed |
| pubmed-article:1363513 | pubmed:author | pubmed-author:BrazzaleAA | lld:pubmed |
| pubmed-article:1363513 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1363513 | pubmed:volume | 12 | lld:pubmed |
| pubmed-article:1363513 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1363513 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1363513 | pubmed:pagination | 2005-10 | lld:pubmed |
| pubmed-article:1363513 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:1363513 | pubmed:meshHeading | pubmed-meshheading:1363513-... | lld:pubmed |
| pubmed-article:1363513 | pubmed:meshHeading | pubmed-meshheading:1363513-... | lld:pubmed |
| pubmed-article:1363513 | pubmed:meshHeading | pubmed-meshheading:1363513-... | lld:pubmed |
| pubmed-article:1363513 | pubmed:meshHeading | pubmed-meshheading:1363513-... | lld:pubmed |
| pubmed-article:1363513 | pubmed:meshHeading | pubmed-meshheading:1363513-... | lld:pubmed |
| pubmed-article:1363513 | pubmed:meshHeading | pubmed-meshheading:1363513-... | lld:pubmed |
| pubmed-article:1363513 | pubmed:meshHeading | pubmed-meshheading:1363513-... | lld:pubmed |
| pubmed-article:1363513 | pubmed:meshHeading | pubmed-meshheading:1363513-... | lld:pubmed |
| pubmed-article:1363513 | pubmed:meshHeading | pubmed-meshheading:1363513-... | lld:pubmed |
| pubmed-article:1363513 | pubmed:meshHeading | pubmed-meshheading:1363513-... | lld:pubmed |
| pubmed-article:1363513 | pubmed:meshHeading | pubmed-meshheading:1363513-... | lld:pubmed |
| pubmed-article:1363513 | pubmed:meshHeading | pubmed-meshheading:1363513-... | lld:pubmed |
| pubmed-article:1363513 | pubmed:meshHeading | pubmed-meshheading:1363513-... | lld:pubmed |
| pubmed-article:1363513 | pubmed:articleTitle | Immunoenzymatic assay of erbB2 protein in cancer and non-malignant breast tissue. Relationships with clinical and biochemical parameters. | lld:pubmed |
| pubmed-article:1363513 | pubmed:affiliation | Center for the Study of Biological Markers of Malignancy, Regional General Hospital, Venice, Italy. | lld:pubmed |
| pubmed-article:1363513 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1363513 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:1363513 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1363513 | lld:pubmed |
